Jennifer K. Litton - Researcher Profile

Publications

1 shown

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton , Hope S. Rugo , Johannes Ettl +15 more

Among patients with advanced breast cancer and a germline BRCA1/2 mutation, single-agent talazoparib provided a significant benefit over standard chemotherapy with respect to pr...

2018 New England Journal of Medicine 1983 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 1
Citations: 1,983
Institution: The University of Texas MD Anderson Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8390-4985

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.

Publications

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Frequent Co-Authors

Hope S. Rugo

Johannes Ettl

Sara A. Hurvitz

Anthony Gonçalvès

Kyung-Hun Lee

Louis Fehrenbacher

Researcher Info

External Links

Identifiers

Impact Metrics